☰

Senthilkumar S. Karuppagounder, Ph.D. - Publications

Affiliations: 
2002-2004 Biomedical sciences Jadavpur University, Kolkata, West Bengal, India 
 2004-2006 Cell Biology & Physiology Indian inst. of Chemical Engineering 
 2006-2009 Pharmacal Science Auburn University, Auburn, AL, United States 
 2009- Neurology Johns Hopkins University School of Medicine, Baltimore, MD, United States 
Area:
Parkinson's Disease, Neurodegeneration, Synaptic Transmission, hippocampal glutamatergic system, AMPA and NMDA channels
Tree Info Grants Similar researchers PubMed Report error

45/60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Kumar M, Acevedo-Cintrón J, Jhaldiyal A, Wang H, Andrabi SA, Eacker S, Karuppagounder SS, Brahmachari S, Chen R, Kim H, Ko HS, Dawson VL, Dawson TM. Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons. Stem Cell Reports. PMID 32795422 DOI: 10.1016/J.Stemcr.2020.07.013  0.775
2020 Pirooznia SK, Yuan C, Khan MR, Karuppagounder SS, Wang L, Xiong Y, Kang SU, Lee Y, Dawson VL, Dawson TM. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency. Molecular Neurodegeneration. 15: 17. PMID 32138754 DOI: 10.1186/S13024-020-00363-X  0.726
2020 Panicker N, Kam T, Neifert S, Hinkle J, Mao X, Karuppagounder S, Wang H, Kumar M, Pirooznia S, Pletnikova O, Troncoso J, Dawson VL, Dawson TM. NLRP3 inflammasome activation in dopamine neurons contributes to neurodegeneration in Parkinson’s Disease The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.01881  0.804
2019 Lei X, Liu L, Terrillion CE, Karuppagounder SS, Cisternas P, Lay M, Martinelli DC, Aja S, Dong X, Pletnikov MV, Wong GW. FAM19A1, a brain-enriched and metabolically responsive neurokine, regulates food intake patterns and mouse behaviors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201901232RR. PMID 31689372 DOI: 10.1096/Fj.201901232Rr  0.314
2019 Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, et al. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Neuron. PMID 31255487 DOI: 10.1016/J.Neuron.2019.05.035  0.8
2019 Brahmachari S, Lee S, Kim S, Yuan C, Karuppagounder SS, Ge P, Shi R, Kim EJ, Liu A, Kim D, Quintin S, Jiang H, Kumar M, Yun SP, Kam TI, et al. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease. Brain : a Journal of Neurology. PMID 31237944 DOI: 10.1093/Brain/Awz172  0.801
2018 Xue Y, Zhan X, Sun S, Karuppagounder SS, Xia S, Dawson VL, Dawson TM, Laterra J, Zhang J, Ying M. Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons. Stem Cells Translational Medicine. PMID 30387318 DOI: 10.1002/Sctm.18-0036  0.715
2018 Kam TI, Mao X, Park H, Chou SC, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S, Panicker N, Chen R, Andrabi SA, Qi C, Poirier GG, Pletnikova O, Troncoso JC, et al. Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease. Science (New York, N.Y.). 362. PMID 30385548 DOI: 10.1126/Science.Aat8407  0.81
2018 Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, Kim S, Oh N, Kim NA, Lee S, Brahmachari S, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. Nature Medicine. PMID 29892066 DOI: 10.1038/S41591-018-0051-5  0.81
2018 Xiong Y, Neifert S, Karuppagounder SS, Liu Q, Stankowski JN, Lee BD, Ko HS, Lee Y, Grima JC, Mao X, Jiang H, Kang SU, Swing DA, Iacovitti L, Tessarollo L, et al. Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 29386392 DOI: 10.1073/Pnas.1712648115  0.792
2018 Kim S, Yun SP, Lee S, Umanah GE, Bandaru VVR, Yin X, Rhee P, Karuppagounder SS, Kwon SH, Lee H, Mao X, Kim D, Pandey A, Lee G, Dawson VL, et al. GBA1 deficiency negatively affects physiological α-synuclein tetramers and related multimers. Proceedings of the National Academy of Sciences of the United States of America. PMID 29311330 DOI: 10.1073/Pnas.1700465115  0.774
2018 Yun SP, Kim D, Kim S, Kim S, Karuppagounder SS, Kwon SH, Lee S, Kam TI, Lee S, Ham S, Park JH, Dawson VL, Dawson TM, Lee Y, Ko HS. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Molecular Neurodegeneration. 13: 1. PMID 29310663 DOI: 10.1186/S13024-017-0233-5  0.73
2017 Brahmachari S, Karuppagounder SS, Ge P, Lee S, Dawson VL, Dawson TM, Ko HS. c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential. Journal of Parkinson's Disease. 7: 589-601. PMID 29103051 DOI: 10.3233/Jpd-171191  0.774
2017 Xiong Y, Neifert S, Karuppagounder SS, Stankowski JN, Lee BD, Grima JC, Chen G, Ko HS, Lee Y, Swing D, Tessarollo L, Dawson TM, Dawson VL. Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology. Eneuro. 4. PMID 28321439 DOI: 10.1523/ENEURO.0004-17.2017  0.705
2017 Pignatelli M, Umanah GK, Ribeiro SP, Chen R, Karuppagounder SS, Yau HJ, Eacker S, Dawson VL, Dawson TM, Bonci A. Synaptic Plasticity onto Dopamine Neurons Shapes Fear Learning. Neuron. 93: 425-440. PMID 28103482 DOI: 10.1016/J.Neuron.2016.12.030  0.787
2016 Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, Ge P, Umanah GE, Brahmachari S, Shin JH, Kang HC, Zhang J, Xu J, Chen R, Park H, et al. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science (New York, N.Y.). 353. PMID 27708076 DOI: 10.1126/Science.Aah3374  0.787
2016 Jiang H, Kang SU, Zhang S, Karuppagounder S, Xu J, Lee YK, Kang BG, Lee Y, Zhang J, Pletnikova O, Troncoso JC, Pirooznia S, Andrabi SA, Dawson VL, Dawson TM. Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons. Eneuro. 3. PMID 27622213 DOI: 10.1523/ENEURO.0183-16.2016  0.786
2016 Brahmachari S, Ge P, Lee SH, Kim D, Karuppagounder SS, Kumar M, Mao X, Lee Y, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, Ko HS. Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration. The Journal of Clinical Investigation. PMID 27348587 DOI: 10.1172/Jci85456  0.8
2016 Thrash-Williams B, Karuppagounder SS, Bhattacharya D, Ahuja M, Suppiramaniam V, Dhanasekaran M. Methamphetamine-induced dopaminergic toxicity prevented owing to the neuroprotective effects of salicylic acid. Life Sciences. PMID 26926078 DOI: 10.1016/J.Lfs.2016.02.072  0.71
2016 Karuppagounder SS, Xiong Y, Lee Y, Lawless MC, Kim D, Nordquist E, Martin I, Ge P, Brahmachari S, Jhaldiyal A, Kumar M, Andrabi SA, Dawson TM, Dawson VL. LRRK2 G2019S Transgenic Mice Display Increased Susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Mediated Neurotoxicity. Journal of Chemical Neuroanatomy. PMID 26808467 DOI: 10.1016/J.Jchemneu.2016.01.007  0.782
2015 Lee Y, Karuppagounder SS, Shin JH, Lee YI, Ko HS, Swing D, Jiang H, Kang SU, Lee BD, Kang HC, Kim D, Tessarollo L, Dawson VL, Dawson TM. Corrigendum: Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nature Neuroscience. 18: 1861. PMID 26605883 DOI: 10.1038/Nn1215-1861A  0.686
2014 Lu W, Karuppagounder SS, Springer DA, Allen MD, Zheng L, Chao B, Zhang Y, Dawson VL, Dawson TM, Lenardo M. Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson's-like movement disorder. Nature Communications. 5: 4930. PMID 25222142 DOI: 10.1038/Ncomms5930  0.711
2014 Andrabi SA, Umanah GK, Chang C, Stevens DA, Karuppagounder SS, Gagné JP, Poirier GG, Dawson VL, Dawson TM. Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proceedings of the National Academy of Sciences of the United States of America. 111: 10209-14. PMID 24987120 DOI: 10.1073/Pnas.1405158111  0.69
2014 Sagal J, Zhan X, Xu J, Tilghman J, Karuppagounder SS, Chen L, Dawson VL, Dawson TM, Laterra J, Ying M. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Translational Medicine. 3: 888-98. PMID 24904172 DOI: 10.5966/Sctm.2013-0213  0.749
2014 Karuppagounder SS, Brahmachari S, Lee Y, Dawson VL, Dawson TM, Ko HS. The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease. Scientific Reports. 4: 4874. PMID 24786396 DOI: 10.1038/Srep04874  0.746
2014 Xiao J, Li Y, Prandovszky E, Karuppagounder SS, Talbot CC, Dawson VL, Dawson TM, Yolken RH. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience. 268: 128-38. PMID 24657774 DOI: 10.1016/J.Neuroscience.2014.03.015  0.662
2014 Karuppagounder SS, Bhattacharya D, Ahuja M, Suppiramaniam V, Deruiter J, Clark R, Dhanasekaran M. Elucidating the neurotoxic effects of MDMA and its analogs. Life Sciences. 101: 37-42. PMID 24560859 DOI: 10.1016/J.Lfs.2014.02.010  0.74
2013 Lee Y, Karuppagounder SS, Shin JH, Lee YI, Ko HS, Swing D, Jiang H, Kang SU, Lee BD, Kang HC, Kim D, Tessarollo L, Dawson VL, Dawson TM. Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nature Neuroscience. 16: 1392-400. PMID 23974709 DOI: 10.1038/Nn.3500  0.746
2013 Thrash-Williams B, Ahuja M, Karuppagounder SS, Uthayathas S, Suppiramaniam V, Dhanasekaran M. Assessment of therapeutic potential of amantadine in methamphetamine induced neurotoxicity. Neurochemical Research. 38: 2084-94. PMID 23918203 DOI: 10.1007/S11064-013-1117-X  0.792
2013 Uthayathas S, Parameshwaran K, Karuppagounder SS, Ahuja M, Dhanasekaran M, Suppiramaniam V. Selective inhibition of phosphodiesterase 5 enhances glutamatergic synaptic plasticity and memory in mice. Synapse (New York, N.Y.). 67: 741-7. PMID 23620198 DOI: 10.1002/Syn.21676  0.765
2013 Vandiver MS, Paul BD, Xu R, Karuppagounder S, Rao F, Snowman AM, Ko HS, Lee YI, Dawson VL, Dawson TM, Sen N, Snyder SH. Sulfhydration mediates neuroprotective actions of parkin. Nature Communications. 4: 1626. PMID 23535647 DOI: 10.1038/Ncomms2623  0.728
2013 Madathil SK, Karuppagounder SS, Mohanakumar KP. Sodium salicylate protects against rotenone-induced parkinsonism in rats. Synapse (New York, N.Y.). 67: 502-14. PMID 23447126 DOI: 10.1002/Syn.21658  0.332
2013 Karuppagounder SS, Madathil SK, Pandey M, Haobam R, Rajamma U, Mohanakumar KP. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats. Neuroscience. 236: 136-48. PMID 23357119 DOI: 10.1016/J.Neuroscience.2013.01.032  0.303
2012 Karuppagounder SS, Ahuja M, Buabeid M, Parameshwaran K, Abdel-Rehman E, Suppiramaniam V, Dhanasekaran M. Investigate the chronic neurotoxic effects of diquat. Neurochemical Research. 37: 1102-11. PMID 22331545 DOI: 10.1007/S11064-012-0715-3  0.809
2012 Parameshwaran K, Buabeid MA, Karuppagounder SS, Uthayathas S, Thiruchelvam K, Shonesy B, Dityatev A, Escobar MC, Dhanasekaran M, Suppiramaniam V. Developmental nicotine exposure induced alterations in behavior and glutamate receptor function in hippocampus. Cellular and Molecular Life Sciences : Cmls. 69: 829-41. PMID 22033836 DOI: 10.1007/S00018-011-0805-4  0.748
2012 Shonesy BC, Thiruchelvam K, Parameshwaran K, Rahman EA, Karuppagounder SS, Huggins KW, Pinkert CA, Amin R, Dhanasekaran M, Suppiramaniam V. Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents. Neurobiology of Aging. 33: 430.e5-18. PMID 21256630 DOI: 10.1016/J.Neurobiolaging.2010.12.002  0.763
2010 Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proceedings of the National Academy of Sciences of the United States of America. 107: 16691-6. PMID 20823226 DOI: 10.1073/Pnas.1006083107  0.706
2010 Thrash B, Karuppagounder SS, Uthayathas S, Suppiramaniam V, Dhanasekaran M. Neurotoxic effects of methamphetamine. Neurochemical Research. 35: 171-9. PMID 19697126 DOI: 10.1007/S11064-009-0042-5  0.781
2008 Dhanasekaran M, Karuppagounder SS, Uthayathas S, Wold LE, Parameshwaran K, Jayachandra Babu R, Suppiramaniam V, Brown-Borg H. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content. Life Sciences. 83: 92-5. PMID 18565546 DOI: 10.1016/J.Lfs.2008.04.016  0.767
2008 Dhanasekaran M, Albano CB, Pellet L, Karuppagounder SS, Uthayathas S, Suppiramaniam V, Brown-Borg H, Ebadi M. Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity. Neurochemical Research. 33: 980-4. PMID 17768676 DOI: 10.1007/S11064-007-9468-9  0.789
2008 Shonesy BC, Kariharan T, Karuppagounder SS, Suppiramaniam V. P4-280: Brain-specific insulin resistance leads to postsynaptic deficits in glutamatergic pathways of the hippocampus Alzheimer's & Dementia. 4: T753-T753. DOI: 10.1016/J.Jalz.2008.05.2349  0.743
2007 Thrash B, Uthayathas S, Karuppagounder SS, Suppiramaniam V, Dhanasekaran M. Paraquat and maneb induced neurotoxicity. Proceedings of the Western Pharmacology Society. 50: 31-42. PMID 18605226  0.803
2007 Uthayathas S, Karuppagounder SS, Tamer SI, Parameshwaran K, Degim T, Suppiramaniam V, Dhanasekaran M. Evaluation of neuroprotective and anti-fatigue effects of sildenafil. Life Sciences. 81: 988-92. PMID 17825848 DOI: 10.1016/J.Lfs.2007.07.018  0.797
2007 Uthayathas S, Karuppagounder SS, Thrash BM, Parameshwaran K, Suppiramaniam V, Dhanasekaran M. Versatile effects of sildenafil: recent pharmacological applications. Pharmacological Reports : Pr. 59: 150-63. PMID 17556793  0.752
2006 Dhanasekaran M, Uthayathas S, Karuppagounder SS, Parameshwaran K, Suppiramaniam V, Ebadi M, Brown-Borg HM. Ebselen effects on MPTP-induced neurotoxicity. Brain Research. 1118: 251-4. PMID 16956591 DOI: 10.1016/J.Brainres.2006.08.020  0.797
Low-probability matches (unlikely to be authored by this person)
2013 Madathil KS, Karuppagounder SS, Haobam R, Varghese M, Rajamma U, Mohanakumar KP. Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats. Neurochemistry International. 62: 674-83. PMID 23353925 DOI: 10.1016/J.Neuint.2013.01.007  0.294
2015 Aleyasin H, Karuppagounder SS, Kumar A, Sleiman S, Basso M, Ma T, Siddiq A, Chinta SJ, Brochier C, Langley B, Haskew-Layton R, Bane SL, Riggins GJ, Gazaryan I, Starkov AA, et al. Antihelminthic benzimidazoles are novel HIF activators that prevent oxidative neuronal death via binding to tubulin. Antioxidants & Redox Signaling. 22: 121-34. PMID 24766300 DOI: 10.1089/Ars.2013.5595  0.25
2005 Ke ZJ, Calingasan NY, Karuppagounder SS, DeGiorgio LA, Volpe BT, Gibson GE. CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. Journal of Neuroimmunology. 164: 85-92. PMID 15904977 DOI: 10.1016/j.jneuroim.2005.04.002  0.237
2008 Karuppagounder SS, Xu H, Pechman D, Chen LH, DeGiorgio LA, Gibson GE. Translocation of amyloid precursor protein C-terminal fragment(s) to the nucleus precedes neuronal death due to thiamine deficiency-induced mild impairment of oxidative metabolism. Neurochemical Research. 33: 1365-72. PMID 18317926 DOI: 10.1007/s11064-008-9594-z  0.226
2014 Sleiman SF, Olson DE, Bourassa MW, Karuppagounder SS, Zhang YL, Gale J, Wagner FF, Basso M, Coppola G, Pinto JT, Holson EB, Ratan RR. Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14328-37. PMID 25339746 DOI: 10.1523/Jneurosci.1010-14.2014  0.221
2009 Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochemistry International. 54: 111-8. PMID 19041676 DOI: 10.1016/J.Neuint.2008.10.008  0.211
2013 Speer RE, Karuppagounder SS, Basso M, Sleiman SF, Kumar A, Brand D, Smirnova N, Gazaryan I, Khim SJ, Ratan RR. Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke. Free Radical Biology & Medicine. 62: 26-36. PMID 23376032 DOI: 10.1016/j.freeradbiomed.2013.01.026  0.21
2009 Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H, Beal MF, Gandy SE, Gibson GE. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model. Neurobiology of Aging. 30: 1587-600. PMID 18406011 DOI: 10.1016/J.Neurobiolaging.2007.12.013  0.209
2007 Shi Q, Karuppagounder SS, Xu H, Pechman D, Chen H, Gibson GE. Responses of the mitochondrial alpha-ketoglutarate dehydrogenase complex to thiamine deficiency may contribute to regional selective vulnerability. Neurochemistry International. 50: 921-31. PMID 17482317 DOI: 10.1016/j.neuint.2007.03.010  0.203
2008 Gibson GE, Karuppagounder SS, Shi Q. Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease. Annals of the New York Academy of Sciences. 1147: 221-32. PMID 19076444 DOI: 10.1196/annals.1427.038  0.196
2011 Sleiman SF, Berlin J, Basso M, Karuppagounder SS, Rohr J, Ratan RR. Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration. Pharmaceuticals (Basel, Switzerland). 4: 1183-1195. PMID 22582024 DOI: 10.3390/Ph4081183  0.166
2013 Karuppagounder SS, Basso M, Sleiman SF, Ma TC, Speer RE, Smirnova NA, Gazaryan IG, Ratan RR. In vitro ischemia suppresses hypoxic induction of hypoxia-inducible factor-1α by inhibition of synthesis and not enhanced degradation. Journal of Neuroscience Research. 91: 1066-75. PMID 23456821 DOI: 10.1002/jnr.23204  0.155
2015 Karuppagounder SS, Kumar A, Shao DS, Zille M, Bourassa MW, Caulfield JT, Alim I, Ratan RR. Metabolism and epigenetics in the nervous system: Creating cellular fitness and resistance to neuronal death in neurological conditions via modulation of oxygen-, iron-, and 2-oxoglutarate-dependent dioxygenases. Brain Research. PMID 26232572 DOI: 10.1016/j.brainres.2015.07.030  0.146
2007 Karuppagounder SS, Shi Q, Xu H, Gibson GE. Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism. Neurobiology of Disease. 26: 353-62. PMID 17398105 DOI: 10.1016/j.nbd.2007.01.011  0.144
2012 Karuppagounder SS, Ratan RR. Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1347-61. PMID 22415525 DOI: 10.1038/jcbfm.2012.28  0.114
Hide low-probability matches.